Arena Pharma (ARNA) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- CoreWeave stock drops on dilution fears and debt concerns
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
- Oracle and these 6 stocks are newest addition to Mizuho Top Picks list
- Anthropic launches cyber defense program for infrastructure and open-source
- Devon Energy to sell Eagle Ford assets to Crescent Energy for $4.2B
Arena Pharma (ARNA) Taps Epirus Biopharma's Munshi as CEO
May 9, 2016 4:07 PM EDTArena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced that it has appointed Amit D. Munshi as President, Chief Executive Officer and interim principal financial officer, effective May 11, 2016. Mr. Munshi will also join Arena's Board of Directors following Arena's 2016 annual stockholders' meeting, which is scheduled for June 13, 2016.
Mr. Munshi brings to Arena more than 25 years of global biopharmaceutical industry experience in executive management, business development, product development and portfolio management. Harry F. Hixson, Jr., Ph.D., who has served as Arena's interim Chief Executive Officer and interim principal financial officer since October 2015 and as a... More



